Dicerna Pharmaceuticals Inc (OQ:DRNA)

Business Focus: Bio Therapeutic Drugs

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 16/20 Mar 12/20 Doberstein Stephen K Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,185  
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Common Stock S - Open market or private sale -8,185 $21.00
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,185 $3.42
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,360  
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Common Stock S - Open market or private sale -4,360 $20.61
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,360 $2.97
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,535  
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,650  
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Common Stock S - Open market or private sale -8,185 $21.00
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 16/20 Mar 12/20 Doberstein Stephen K Direct Ownership Director Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,185  
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Common Stock S - Open market or private sale -8,185 $21.00
Mar 3/20 Mar 2/20 Brown Bob D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,185 $3.42
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -4,360  
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Common Stock S - Open market or private sale -4,360 $20.61
Mar 3/20 Mar 2/20 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,360 $2.97
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,535  
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -5,650  
Feb 11/20 Feb 10/20 Brown Bob D Direct Ownership Common Stock S - Open market or private sale -8,185 $21.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $DRNA